Predictors Factors of Uncontrolled Masked Hypertension (MUCH) in Patients with Chronic Kidney Disease (CKD)

Roberto Santos Junior1, Gabriel Fernandes Silva2, Luciano Ferreira Drager1

  • 1Faculty of Medicine, University of São Paulo (USP), São Paulo 01246-903, SP, Brazil.

PubMed

Insights

Masked uncontrolled hypertension (MUCH) is common in chronic kidney disease (CKD) patients. Higher diastolic blood pressure, lower BMI, and elevated albuminuria predict MUCH in this high-risk group.

Area of Science:

  • Nephrology
  • Cardiology
  • Hypertension Research

Background:

  • Masked uncontrolled hypertension (MUCH) is a prevalent phenotype in patients with chronic kidney disease (CKD).
  • MUCH is associated with increased risks of cardiovascular morbidity and mortality.
  • Identifying predictors of MUCH in CKD patients is critical for early intervention and risk management.

Purpose of the Study:

  • To identify factors predicting the masked uncontrolled hypertension (MUCH) phenotype in patients with chronic kidney disease (CKD).
  • To develop a predictive model for MUCH in hypertensive CKD patients with in-office normotension.

Main Methods:

  • A 7-year observational study (2017-2023) included hypertensive patients with CKD and in-office normotension.
  • Ambulatory blood pressure monitoring (ABPM) classified patients into controlled hypertension (CH) or MUCH.
  • Epidemiological, clinical, anthropometric, and laboratory data were analyzed to build a predictor model.

Main Results:

  • Nearly half (49.5%) of the 220 participants had MUCH.
  • Predictors of MUCH included higher diastolic blood pressure (DBP ≥75 mmHg), lower body mass index (BMI ≤25 Kg/m²), and elevated albuminuria (≥300 mg/g).
  • Significant associations were found: DBP OR 1.93, BMI OR 2.21, and albuminuria OR 3.26.

Conclusions:

  • Masked uncontrolled hypertension (MUCH) is a frequent condition in patients with arterial hypertension and CKD.
  • Diastolic blood pressure ≥75 mmHg, BMI ≤25 Kg/m², and albuminuria ≥300 mg/g are significant predictors of MUCH in this population.
  • These findings aid in identifying CKD patients at higher risk for MUCH and associated cardiovascular complications.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.8K
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.7K
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
401
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
30
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
440
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
305